Handbook/Tissue Repair & Healing/BPC-157 + TB-500 Combo (5mg+5mg)

BPC-157 + TB-500 Combo (5mg+5mg)

Featured

Also known as: BPC/TB Stack, Healing Duo 5mg, Wolverine Stack

A pre-mixed combination of BPC-157 and TB-500 for enhanced tissue healing.

Overview

This combination pre-mixes BPC-157 and TB-500 at equal 5mg doses for convenient healing protocols. BPC-157 promotes angiogenesis and GI healing while TB-500 enhances cell migration and reduces inflammation. Together they provide comprehensive tissue repair support.

Mechanism of Action

BPC-157: upregulates growth factors (VEGF, FGF), promotes angiogenesis, protects GI tract. TB-500: upregulates actin, promotes cell migration, anti-inflammatory. Combined effects target multiple healing pathways.

Pharmacokinetics

Each component has its own kinetics. BPC-157 half-life ~4 hours, TB-500 longer. Subcutaneous or intramuscular.

Dosing Protocols

Note: These are research protocols from literature. This is not medical advice.

1

Healing Protocol

Dose

250-500 mcg each

Frequency

Daily or 5 days/week

Duration

4-8 weeks

Typical healing cycle

Stacking Recommendations

Peptides that may be combined based on complementary mechanisms in research settings.

Rationale: Additional healing

Synergy: Third healing pathway

Research Areas

Tissue RepairMuscle HealingTendon/LigamentJoint HealthWound HealingGI Repair

Key Research Findings

  • 1Two most popular healing peptides combined
  • 2Complementary mechanisms
  • 3Convenience of single vial
  • 4Well-established individual safety profiles

Side Effects & Contraindications

Reported Side Effects

  • Injection site reactions
  • Headache (rare)
  • Fatigue

Contraindications

  • Active cancer (theoretical)
  • Recent surgery (wait for MD clearance)

Safety Considerations

Research compounds. Individual components well-studied. Combination safety not separately validated but likely similar to individual use.

Storage Requirements

Refrigerate 2-8°C after reconstitution

Scientific References

Quick Reference

Sequence
Combination product
Molecular Weight
Variable
Half-Life
Variable by component
Bioavailability
Injectable
Research Stage
preclinical
Administration
Subcutaneous injection